Preprint Hypothesis Version 1 Preserved in Portico This version is not peer-reviewed

On the Consequences of Cell Fusion in COVID-19 Patients

Yuri Lazebnik
*
Version 1 : Received: 2 June 2021 / Approved: 4 June 2021 / Online: 4 June 2021 (08:21:00 CEST)
Version 2 : Received: 7 September 2021 / Approved: 9 September 2021 / Online: 9 September 2021 (10:54:14 CEST)

A peer-reviewed article of this Preprint also exists.

Lazebnik, Y. Cell Fusion as a Link between the SARS-CoV-2 Spike Protein, COVID-19 Complications, and Vaccine Side Effects. Oncotarget, 2021, 12, 2476–2488. https://doi.org/10.18632/oncotarget.28088. Lazebnik, Y. Cell Fusion as a Link between the SARS-CoV-2 Spike Protein, COVID-19 Complications, and Vaccine Side Effects. Oncotarget, 2021, 12, 2476–2488. https://doi.org/10.18632/oncotarget.28088.

Abstract

This commentary proposes how the coronavirus SARS- CoV-2 can contribute to clinical manifestations of COVID-19 by producing syncytia.

Keywords

cell fusion; syncytia; hybrids; viruses; coronaviruses; SARS-CoV-2; COVID-19; blood coagulation cascade; thrombosis; cancer

Subject

Biology and Life Sciences, Virology

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.